Trials / Completed
CompletedNCT02910284
Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
A Long-term Follow-up Study of Efficacy and Immunogenicity of GEN-003 in Subjects With Genital Herpes Simplex Virus Type 2 (HSV-2) Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- Genocea Biosciences, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study is a follow-up study from Study GEN-003-002 to evaluate long-term efficacy and immunogenicity of GEN-003 in subjects with genital HSV-2 infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Observational |
Timeline
- Start date
- 2016-09-16
- Primary completion
- 2017-07-14
- Completion
- 2017-07-14
- First posted
- 2016-09-22
- Last updated
- 2017-10-20
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02910284. Inclusion in this directory is not an endorsement.